State of Wisconsin Investment Board’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40,000
Closed -$2.04M 2575
2025
Q4
$2.04M Buy
+40,000
New +$2.05M ﹤0.01% 1404

Other funds holding NVO

State of Wisconsin Investment Board's NVO Position: Q1 2026 in Review

State of Wisconsin Investment Board sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 40,000 shares — an estimated $2.04M sold.

State of Wisconsin Investment Board first reported a position in NVO in Q4 2025 and held it in 1 quarter. The position peaked at $2.04M in Q4 2025. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • State of Wisconsin Investment Board reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 40,000 Novo Nordisk shares in Q1 2026, an estimated $2.04M.
  • State of Wisconsin Investment Board first reported a position in Novo Nordisk in Q4 2025 and held it in 1 quarter.
  • State of Wisconsin Investment Board's Novo Nordisk position peaked at $2.04M in Q4 2025.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.